Literature DB >> 23975491

Human papillomavirus and tobacco use in tongue base cancers.

Daniel L Stoler1, Philip J Smaldino, Huferesh K Darbary, Maureen A Sullivan, Saurin R Popat, Wesley L Hicks, Mihai Merzianu, Daniel P Gaile, Garth R Anderson, Thom R Loree.   

Abstract

Human papillomavirus 16 (HPV-16) infection and tobacco use are associated with human oropharyngeal cancers. We conducted a study of the role of HPV and tobacco use in base of the tongue (BOT) cancers. DNA from 34 such cancers was subjected to HPV-16 and HPV-18-specific polymerase chain reaction analysis. Demographic and clinicopathologic data were obtained from each patient's medical record. HPV-16 was detected in 68% of tumors. Tobacco use was the only factor found to be significantly associated with HPV status. Tumors from 100% of patients who had never used tobacco tested positive for HPV, compared with only 56% of those who had ever used tobacco (Fisher exact test, p = 0.024). All tumors were associated with either tobacco use or HPV infection. These findings are consistent with the hypothesis that either tobacco use or HPV infection is necessary to the etiology of BOT tumors, and they suggest that tongue base carcinoma may be prevented by combining HPV vaccination with tobacco avoidance.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23975491     DOI: 10.1177/014556131309200812

Source DB:  PubMed          Journal:  Ear Nose Throat J        ISSN: 0145-5613            Impact factor:   1.697


  3 in total

1.  Prevalence and risk factors for oral DNA tumor viruses in HIV-infected youth.

Authors:  Jessica A Kahn; Bret J Rudy; Jiahong Xu; Bill Kapogiannis; Elizabeth Secord; Maura Gillison
Journal:  J Med Virol       Date:  2016-05-09       Impact factor: 2.327

2.  Increasing incidence of base of tongue cancers from 2000 to 2010 due to HPV: the largest demographic study of 210 Danish patients.

Authors:  E Garnaes; K Kiss; L Andersen; M H Therkildsen; M B Franzmann; B Filtenborg-Barnkob; E Hoegdall; C B Lajer; E Andersen; L Specht; L Joenson; K Frederiksen; L Friis-Hansen; F C Nielsen; S K Kjaer; B Norrild; C von Buchwald
Journal:  Br J Cancer       Date:  2015-06-04       Impact factor: 7.640

3.  Selective participation of c-Jun with Fra-2/c-Fos promotes aggressive tumor phenotypes and poor prognosis in tongue cancer.

Authors:  Shilpi Gupta; Prabhat Kumar; Harsimrut Kaur; Nishi Sharma; Daman Saluja; Alok C Bharti; Bhudev C Das
Journal:  Sci Rep       Date:  2015-11-19       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.